反応式
C[C:2]1([CH3:10])[CH2:7][CH2:6][CH2:5][C:4]([CH3:9])(C)N1.[CH3:11][C:12](=[O:17])[CH2:13][C:14](=[O:16])[CH3:15]>C(N(CC)CC)C>[C:4]1([CH:9]=[CH:11][C:12](=[O:17])[CH2:13][C:14](=[O:16])[CH3:15])[CH:5]=[CH:6][CH:7]=[CH:2][CH:10]=1参加物
4
実験手順
The title compound was prepared by the method of Example 6 (that is, using 2,2,6,6-tetramethylpiperidine as base instead of triethylamine) using 2,4-pentanedione instead of ethyl acetoacetate. The material prepared by this procedure was identical to that prepared by the method of Example 30, as indicated by the reverse phase chromatographic method described in Example 2.
後処理
- customThe material prepared by this procedure
- customthat prepared by the method of Example 30
出典と根拠
- ORDレコード
- ord-7a2e1349a9674e6e93d465cf501a1fb5
- 出典データセット
- uspto-grants-1988_08
- 特許番号
- US04761503
関連ノート
読み込み中…